Abstract

Modeling thrombus growth in pathological flows allows evaluation of risk under patient-specific pharmacological, hematological, and hemodynamical conditions. We have developed a 3D multiscale framework for the prediction of thrombus growth under flow on a spatially resolved surface presenting collagen and tissue factor (TF). The multiscale framework is composed of four coupled modules: a Neural Network (NN) that accounts for platelet signaling, a Lattice Kinetic Monte Carlo (LKMC) simulation for tracking platelet positions, a Finite Volume Method (FVM) simulator for solving convection-diffusion-reaction equations describing agonist release and transport, and a Lattice Boltzmann (LB) flow solver for computing the blood flow field over the growing thrombus. A reduced model of the coagulation cascade was embedded into the framework to account for TF-driven thrombin production. The 3D model was first tested against in vitro microfluidics experiments of whole blood perfusion with various antiplatelet agents targeting COX-1, P2Y1, or the IP receptor. The model was able to accurately capture the evolution and morphology of the growing thrombus. Certain problems of 2D models for thrombus growth (artifactual dendritic growth) were naturally avoided with realistic trajectories of platelets in 3D flow. The generalizability of the 3D multiscale solver enabled simulations of important clinical situations, such as cylindrical blood vessels and acute flow narrowing (stenosis). Enhanced platelet-platelet bonding at pathologically high shear rates (e.g., von Willebrand factor unfolding) was required for accurately describing thrombus growth in stenotic flows. Overall, the approach allows consideration of patient-specific platelet signaling and vascular geometry for the prediction of thrombotic episodes.

Highlights

  • During atherosclerotic plaque rupture that triggers thrombus growth, platelets respond to a combination of stimuli from multiple agonists, such as exposure to collagen and plateletreleased ADP and thromboxane (TXA2)

  • Recognizing that the physics of hemodynamic flow and thrombus growth is inherently 3D, we have extended a multiscale model of platelet aggregation under flow in a 2D rectangular domain to solve the problem on a generalized 3D domain [11,16]

  • We validated our multiscale model by comparing model predictions to in vitro experiments of whole blood perfusion in an 8-channel microfluidic device; see Figs 2A and 2D

Read more

Summary

Introduction

During atherosclerotic plaque rupture that triggers thrombus growth, platelets respond to a combination of stimuli from multiple agonists, such as exposure to collagen and plateletreleased ADP and thromboxane (TXA2). Tissue factor (TF) at the site of injury leads to the production of thrombin, another potent platelet agonist. These stimuli drive signaling pathways within platelets that elevate intracellular calcium, activate β1 and β3 integrins, and release α and dense granules. Excessive platelet deposition and aggregation due to platelet hyperactivity at the site of plaque rupture within the circulatory system (thrombosis) is known to initiate heart attacks and strokes. Quantifying the dynamics of thrombus growth and response to drug treatments would be an essential diagnostic tool for the evaluation of pharmacological options

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call